paclitaxel

(redirected from Abraxane)
Also found in: Medical.

pac·li·tax·el

 (păk′lĭ-tăk′səl)
n.
An anticancer drug that was first derived from the bark of the Pacific yew tree and is used in the treatment of ovarian and breast cancer that has not responded to prior therapy.

[Pac(ific yew) + New Latin (brevifō)li(a), specific epithet of the Pacific yew (Latin brevis, short + Latin fōlium, leaf; see folium) + alteration of Taxol.]

paclitaxel

(ˌpæklɪˈtæksəl)
n
(Medicine) a drug derived from the yew tree and used to treat cancer
Translations

paclitaxel

n paclitaxel m
Mentioned in ?
References in periodicals archive ?
M2 PHARMA-January 23, 2018-Celgene Reports LAPACT Trial Results on Abraxane Regimen for Patients with Locally Advanced Pancreatic Cancer
Celgene announced primary endpoint findings and updated results of secondary endpoints from the phase II international LAPACT trial of Abraxane plus gemcitabine in patients with locally advanced pancreatic cancer.
The National Institute for Health and Care Excellence (Nice) decided not to recommend Abraxane for use within the NHS in England or Wales in October 2015.
From today Abraxane, used to treat metastatic pancreatic cancer, has been confirmed for continued use by the All Wales Medicine Strategy Group.
Health Minister Drakeford said: "I'm pleased to confirm the Welsh Government has finalised an access agreement with Celgene to enable continued availability of Abraxane for Welsh patients with pancreatic cancer.
have entered a collaboration to evaluate the safety and efficacy of a combination regimen of BMS' investigational PD-1 immune checkpoint inhibitor, OPDIVO (nivolumab), and Celgene's nab technology-based chemotherapy ABRAXANE, in a Phase I study.
Andrew Luck, 43, was pinning his hopes on new metastatic pancreatic cancer treatment Abraxane - which is available in England - to extend his life or even help him beat the illness completely.
A decision to add the recently licensed drug Abraxane to the Cancer Drugs Fund list has been approved - something which Middlesbrough widow Lynne Judd is thrilled about.
Abraxane, used with chemotherapy, increased average survival from 6.
At the end of last week Celgene announced that the FDA has OKaACAOd its added new drug application for ABRAXANE when used in combination with gemcitabine as first-line treatment for late-stage, metastatic pancreatic cancer.
WASHINGTON -- The Food and Drug Administration has approved the use of Celgene's drug Abraxane in patients with late-stage (metastatic) pancreatic cancer.
Abraxane was first approved in 2005 for treatment of breast cancer, and is also now approved for non-small cell lung cancer.